NU51CK000359
Cooperative Agreement
Overview
Grant Description
Epidemiology and laboratory capacity for prevention and control of emerging infectious diseases (ELC) CDC-RFA-CK-24-0002 - The epidemiology and laboratory capacity for prevention and control of emerging infectious diseases (ELC) notice of funding opportunity (NOFO) builds upon the program that was initiated in 1995 as one of the key activities under CDC’s plan to address emerging infectious disease threats.
The purpose of this NOFO is to protect the public health and safety of the American people by enhancing the capacity of public health agencies to effectively detect, respond, prevent and control known and emerging (or re-emerging) infectious diseases.
This is accomplished by providing financial and technical resources to (1) strengthen epidemiologic capacity; (2) enhance laboratory capacity; (3) improve information systems; and (4) enhance collaboration among epidemiology, laboratory, and information systems components of public health departments.
ELC funding is critical to support capacity in epidemiology, laboratory, and public health information systems in Indiana.
This capacity includes full-time permanent and contractual positions, supplies, training, laboratory reagents and equipment, and IT infrastructure.
Elimination of this funding would result in loss of capacity to conduct infectious disease surveillance, investigate infectious disease outbreaks, transmit electronic health data, and educate health care providers and the public.
With increasing emerging infectious disease threats such as MPOX, measles, and HPAI, COVID-19, MERS, Ebola virus disease, and antibiotic resistant organisms, maintaining this capacity is vital.
The purpose of this NOFO is to protect the public health and safety of the American people by enhancing the capacity of public health agencies to effectively detect, respond, prevent and control known and emerging (or re-emerging) infectious diseases.
This is accomplished by providing financial and technical resources to (1) strengthen epidemiologic capacity; (2) enhance laboratory capacity; (3) improve information systems; and (4) enhance collaboration among epidemiology, laboratory, and information systems components of public health departments.
ELC funding is critical to support capacity in epidemiology, laboratory, and public health information systems in Indiana.
This capacity includes full-time permanent and contractual positions, supplies, training, laboratory reagents and equipment, and IT infrastructure.
Elimination of this funding would result in loss of capacity to conduct infectious disease surveillance, investigate infectious disease outbreaks, transmit electronic health data, and educate health care providers and the public.
With increasing emerging infectious disease threats such as MPOX, measles, and HPAI, COVID-19, MERS, Ebola virus disease, and antibiotic resistant organisms, maintaining this capacity is vital.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Indiana
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 242601% from $2,695 to $6,540,793.
Indiana Department Of Health was awarded
ELC CDC-RFA-CK-24-0002: Enhancing Infectious Disease Prevention
Cooperative Agreement NU51CK000359
worth $6,540,793
from National Center for Emerging and Zoonotic Infectious Diseases in August 2024 with work to be completed primarily in Indiana United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.317 Emerging Infections Programs.
The Cooperative Agreement was awarded through grant opportunity Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC).
Status
(Ongoing)
Last Modified 9/24/25
Period of Performance
8/1/24
Start Date
7/31/29
End Date
Funding Split
$6.5M
Federal Obligation
$0.0
Non-Federal Obligation
$6.5M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for NU51CK000359
Transaction History
Modifications to NU51CK000359
Additional Detail
Award ID FAIN
NU51CK000359
SAI Number
NU51CK000359-521719255
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVL0 CDC NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES
Awardee UEI
GXFMGZLP95D9
Awardee CAGE
3GXW3
Performance District
IN-90
Senators
Todd Young
Mike Braun
Mike Braun
Modified: 9/24/25